TG Therapeutics TGTX Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's total costs & expenses?
- TG Therapeutics (TGTX) reported total costs & expenses of $170.12M in Q1 2026.
- How has TG Therapeutics's total costs & expenses changed year-over-year?
- TG Therapeutics's total costs & expenses increased by 51.6% year-over-year, from $112.23M to $170.12M.
- What is the long-term trend for TG Therapeutics's total costs & expenses?
- Over 3 years (2021 to 2025), TG Therapeutics's total costs & expenses has grown at a 11.9% compound annual growth rate (CAGR), from $351.46M to $492.96M.
- What does total costs & expenses mean?
- The total amount of money spent on all business operations during a period.
- How do you interpret total costs & expenses?
- Growth in this metric should ideally be outpaced by revenue growth to ensure expanding operating margins.
- How does total costs & expenses compare across companies?
- Standard aggregate metric; used to calculate the total expense burden relative to the company's scale.